BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness

Wednesday, July 29, 2020 1 min read

Key Takeaway: BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness

Full Press Release Details

BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness.